Home
Finance & valuation

Finance & valuation

SVB’s collapse is a reminder of how far IP finance still has to travel

Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it

The Market Makers of 2022: top 20 revealed

Marconi's Kasim Alfalahi takes the top spot for Avanci's stellar showing in our countdown of the patent market’s most innovative and influential dealmakers and decision takers

Patent litigation finance skyrockets in past three years

We compiled data from Westfleet Advisors’ annual litigation funding reports to find patent finance shot up by nearly 50% since 2020 – to the benefit of rights holders

Latest content

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful

The number and value of acquisitions have both tumbled further than in the early months of 2020

20 July 2021

Singapore banking on regional IP rise and dispute resolution to cement its hub status

An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key

19 July 2021

IAM insight panel analysis Q2 2021

Featured in Community Insight

Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices

01 July 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP

29 June 2021

Via Licensing looks to extend its hold on audio space with next-gen patent pool

Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution

23 June 2021

In the mobile licensing world, US patent holdings do not have the power they did

Globalisation in the 5G era has reduced the clout of portfolios centred on the country, but decisions taken by the government, the courts and in boardrooms have hastened the process

17 June 2021

Another startup taps Aon for insurance-backed IP financing

Insurance giant, which recently announced a $400m IP fund, says it has a strong pipeline of lending deals in the works

17 June 2021

$2 billion deal shows growing sophistication of drug royalty sales

Latest Royalty Pharma investment shows is further evidence of the increasing IP monetisation options open to healthcare innovators

15 June 2021

Chinese buyer of 10,000+ LED patents from LG Innotek revealed

Newly-created Suzhou Lekin Semiconductor is backed by a well-connected Chinese lighting magnate

04 June 2021

Xiaomi royalty figures show importance of IP strategy as it grows international footprint

In a banner quarter, company gets off US government blacklist, grows profits, and pays a hefty royalty sum

01 June 2021

Unlock unlimited access to all IAM content